Tumor-associated antigen CAPERα and microvessel density in hepatocellular carcinoma

被引:11
|
作者
Dai, Liping [1 ,2 ]
Peng, Xuan-Xian [3 ]
Tan, Eng M. [4 ]
Zhang, Jian-Ying [1 ,2 ]
机构
[1] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA
[2] Univ Texas El Paso, NIH Sponsored Border Biomed Res Ctr, El Paso, TX 79968 USA
[3] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510006, Guangdong, Peoples R China
[4] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
基金
美国国家卫生研究院;
关键词
CAPER alpha; tumor-associated antigen; hepatocellular carcinoma; cancer biomarkers; tumor angiogenesis; ENDOTHELIAL GROWTH-FACTOR; CANCER PATIENTS; EXPRESSION; ANGIOGENESIS; ANTIBODIES; DISEASE; AUTOANTIBODIES; PROTEINS; MARKERS; CELLS;
D O I
10.18632/oncotarget.7707
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: CAPER alpha, a tumor-associated antigen, was identified from a cDNA clone with autoantibody from a patient with hepatocellular carcinoma (HCC). It has been implicated, by way of alternative splicing of VEGF pre-mRNA, in the regulation of microvessel formation in Ewing's sarcoma. In this study, we looked for possible association of alterations in CAPER alpha with microvessel density in HCC. Methods: Enzyme-linked immunosorbent assay using recombinant CAPER alpha as antigen were used to detect antibody against CAPER alpha. Immunohistochemistry (IHC) on liver sections was performed to analyze expression profiles of CAPER alpha, VEGF and CD34 in HCC and control tissues and was further used to assess the correlation of expression among CAPER alpha, VEGF and CD34 in HCC development. Results: Autoantibody to CAPER alpha was highest in HCC (22/76, 28.9%), not detected in prostate cancer (0/79) and at 3.4% (3/88) in breast cancer. In immunohistochemical analysis of grades II and III HCC tissues, significantly decreased immunostaining for CAPER alpha was observed and this correlated directly with decreased immunostaining for VEGF (R=0.534, P=0.0003). Using CD34 immunostaining for detecting newly formed microvessels, strong staining was observed in grades II and III HCC. Normal liver sections, all of which have high expression of CAPER alpha were totally negative for CD34 immunostaining. A significant inverse correlation was seen between CAPER alpha and CD34 immunostaining (R=-0.481, P=0.0012). Conclusions: Decreased expression of CAPER alpha appears to be correlated with appearance of microvessels. It would be of interest to elucidate the cause of altered CAPER alpha since new formation of microvessels is important in progression of HCC.
引用
收藏
页码:16985 / 16995
页数:11
相关论文
共 50 条
  • [1] Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma
    Noguchi, K
    Enjoji, M
    Nakamuta, M
    Nakashima, M
    Nishi, H
    Choi, I
    Taguchi, K
    Kotoh, K
    Shimada, M
    Sugimachi, K
    Tsuneyoshi, M
    Nawata, H
    Watanabe, T
    CANCER LETTERS, 2001, 168 (02) : 197 - 202
  • [2] Clinical Significance of Tumor-associated Carbohydrate Antigen Globo H in Hepatocellular Carcinoma
    Lin, J. -C.
    Cheng, S. -P.
    Huang, T. -S.
    Ng, X. -Y.
    Liu, C. -L.
    Liu, T. -P.
    TRANSPLANTATION, 2017, 101 (05) : 229 - 229
  • [3] Definition of tumor-associated antigens in hepatocellular carcinoma
    Stenner-Liewen, F
    Luo, GR
    Sahin, U
    Tureci, O
    Koslovski, M
    Kautz, I
    Liewen, H
    Pfreundschuh, M
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2000, 9 (03) : 285 - 290
  • [4] Heterogeneity of tumor-associated neutrophils in hepatocellular carcinoma
    Fan, Guixiang
    Na, Jintong
    Shen, Zhen
    Lin, Faquan
    Zhong, Liping
    MOLECULAR IMMUNOLOGY, 2025, 177 : 1 - 16
  • [5] TUMOR-ASSOCIATED ANTIGEN IN PATIENTS WITH CARCINOMA OF COLON
    LOGERFO, P
    LOGERFO, F
    HERTER, F
    HANSEN, HJ
    BARKER, HG
    AMERICAN JOURNAL OF SURGERY, 1972, 123 (02): : 127 - &
  • [6] High-density lipoprotein modulates tumor-associated macrophage for chemoimmunotherapy of hepatocellular carcinoma
    Wang, Junyang
    Zheng, Chao
    Zhai, Yihui
    Cai, Ying
    Lee, Robert J.
    Xing, Jianming
    Wang, Hao
    Zhu, Helen H.
    Teng, Lesheng
    Li, Yaping
    Zhang, Pengcheng
    NANO TODAY, 2021, 37
  • [7] Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
    Zhou, Dexi
    Luan, Jiajie
    Huang, Cheng
    Li, Jun
    GUT AND LIVER, 2021, 15 (04) : 500 - 516
  • [8] Identification of tumor-associated antigens as markers in hepatocellular carcinoma
    Xu, Xueqin
    Wang, Kaijuan
    Xing, Ying
    Nie, Wei
    Dai, Liping
    Wang, Ping
    Zhang, Jian-Ying
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Role of tumor-associated macrophages in the progression of hepatocellular carcinoma
    Shirabe, Ken
    Mano, Yohei
    Muto, Jun
    Matono, Rumi
    Motomura, Takashi
    Toshima, Takeo
    Takeishi, Kazuki
    Uchiyama, Hidekaki
    Yoshizumi, Tomoharu
    Taketomi, Akinobu
    Morita, Masaru
    Tsujitani, Shunichi
    Sakaguchi, Yoshihisa
    Maehara, Yoshihiko
    SURGERY TODAY, 2012, 42 (01) : 1 - 7
  • [10] Role of tumor-associated macrophages in the progression of hepatocellular carcinoma
    Ken Shirabe
    Yohei Mano
    Jun Muto
    Rumi Matono
    Takashi Motomura
    Takeo Toshima
    Kazuki Takeishi
    Hidekaki Uchiyama
    Tomoharu Yoshizumi
    Akinobu Taketomi
    Masaru Morita
    Shunichi Tsujitani
    Yoshihisa Sakaguchi
    Yoshihiko Maehara
    Surgery Today, 2012, 42 : 1 - 7